Source: PR NEWSWIRE

Press Release: Chiral : Chiral Technologies Acquires Diffinity Genomics

WEST CHESTER, Pennsylvania, Aug. 4, 2015 /PRNewswire/ -- Chiral Technologies, part of DAICEL CORPORATION, the global market leader in enantioselective chromatography, is pleased to announce the acquisition of the assets of Diffinity Genomics® of West...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Joseph Barendt's photo - President & CEO of Chiral

President & CEO

Joseph Barendt

CEO Approval Rating

70/100

Read more